Topic
clinical-research
10 stories related to this topic, newest first.
usatoday.comscience13 hrs ago
Two-Year USC Study Finds High-Dose DHA Supplements Did Not Slow Memory Loss or Brain Shrinkage
A two-year trial at the University of Southern California found that 2,000 mg daily DHA supplements failed to slow cognitive decline or hippocampal atrophy in 365 adults at elevated Alzheimer's risk. Researchers reported a 17 percent rise in cerebrospinal fluid DHA levels but no…
forbes.comscience9 days ago
Meta-analysis finds tirzepatide produced largest weight loss among three GLP-1 drugs
A University of Georgia review of 14,000 non-diabetic patients showed tirzepatide led to more than 20 percent body-weight reduction, compared with roughly 15 percent for semaglutide and 8 percent for liraglutide.
Nprscience21 days ago
GLP-1 Drugs Linked to Lower Cancer Risk in Observational Studies, but Causation Unproven
Analyses presented at the May 2026 American Society of Clinical Oncology meeting found reduced cancer incidence and progression among patients taking GLP-1 obesity treatments.
finance.yahoo.comscience24 days ago
MannKind Presents New Data on Inhaled Insulin at ADA 2026 Meeting
MannKind Corporation presented clinical and real-world findings on its inhaled insulin product at the American Diabetes Association's 2026 Scientific Sessions in New Orleans. The data cover pediatric use, gestational diabetes, and combination with automated insulin delivery syste…
Fox Newsscience28 days ago
Study Finds Four-Week Yoga Program Reduced Insomnia and Fatigue in Cancer Survivors
A randomized trial of 410 cancer survivors found that twice-weekly yoga sessions produced moderate-to-large reductions in mood disturbance and fatigue. The study was presented at the 2026 American Society of Clinical Oncology Annual Meeting.
Fox Newsscience32 days ago
Review Finds Single Ketamine Infusion Reduced Depression Symptoms Within Hours
A review of 26 clinical trials found that one intravenous ketamine dose lowered depression scores in four hours and suicidal thoughts within 24 hours. Effects lasted up to a month for some participants. Researchers noted the drug is not FDA-approved for depression treatment.
forbes.comai38 days ago
Study Compares OpenAI Model Accuracy to Physicians on Hospital Admissions
A study published April 30 in Science tested OpenAI models against internal medicine physicians using records from 76 patients admitted through an emergency department. The o1 model matched or closely matched the final diagnosis in 67 percent of cases, compared with 55 percent an…
ncbi.nlm.nih.govscience38 days ago
GLP-1 Drug Effects on Cancer Remain Unresolved
Medical researcher Eric Topol stated that any potential link between GLP-1 drugs and cancer incidence is not yet confirmed. He noted that observed effects may relate to weight loss rather than independent mechanisms.
ER
Euronewsworld51 days ago
Study Finds People in Diet-and-Walking Programs Averaged 8,500 Daily Steps and Lost Modest Weight Over 3 Months
A new analysis of 14 clinical trials shows that participants who increased their daily steps to around 8,500 during weight loss and maintenance phases sustained an average 3.28 percent reduction in body weight. The research, involving nearly 4,000 overweight or obese adults, was…
france24.combusiness52 days ago
FDA Proposes Removing Gender References From Regulations
The U.S. Food and Drug Administration issued a proposed rule this week to remove references to “gender” from its regulations. The agency cited a 2025 executive order from President Trump directing emphasis on biological sex across federal policies. The change has raised questions…